Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2193 - 2200 of 11685 results
Health Plan Transparency and the Case for Welfare Plan Fiduciary Committees
March 7, 2022| Blog| Viewpoint
ONC Publishes Report, Commentary on Information Blocking Rule Claims Trends
March 7, 2022| News
No Harm, No Foul, and No Standing for Would-be SEP Implementer: 5th Circuit Changes Narrative on Patent “Hold Up”
March 3, 2022| Blog| Viewpoint
Mintz’s Sell-Side Series: Preparing Today for Tomorrow's Sale — Week 1
March 3, 2022| Article| Viewpoint
What's New in 5G - March 2022
March 3, 2022| News
Health Law Diagnosed — Transactions Part 1: Regulatory Trends in Recent Health Care Transactions
March 3, 2022| Podcast| Viewpoint
What Does ESG Mean for Your Organization?
March 3, 2022| Webinar| Viewpoint
Patent Owner Tips for Avoiding IPR Institution
March 1, 2022| Blog| Viewpoint
News & Press Releases
Mintz Expands Energy & Sustainability Practice with Projects & Infrastructure Member Luis F. Torres
January 27, 2025
Luis F. Torres has joined as a Member of Mintz’s Energy & Sustainability Practice in the firm’s Washington, DC and New York offices. An accomplished project finance lawyer, Luis’s practice focuses on the structuring, development, and financing of energy, transport, telecommunications, and other infrastructure projects in the United States, Latin America, and other jurisdictions around the globe.
Mintz represented Quorum Cyber Security, a platform company of Charlesbank Capital Partners, in its acquisition of Kivu Consulting, Inc., a global cybersecurity firm specializing in Incident Response.
Mintz Represents Granata Bio Corporation in Series A+ Funding Round
January 24, 2025
Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round.